Germany· DE-A57-f099b2a2cbabafa7
Lamivudin/Zidovudin Beta
A medicinal product containing zidovudine, lamivudine, registered in Germany by Betapharm Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Zidovudine, Lamivudine
- Manufacturer
- Betapharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zidovudine, lamivudine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCOMBIVIRViiV Healthcare Company
- United KingdomCombivir 150mg/300mg tabletsViiV Healthcare UK Ltd
- FinlandCombivirParanova Oy
- SpainCOMBIVIR 150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- NetherlandsCombivir, tabletten 150/300 mgViiV healthcare B.V.
- FranceCOMBIVIR 150 mg/300 mg, comprimé pelliculéVIIV HEALTHCARE (PAYS-BAS)
- CanadaAPO-LAMIVUDINE-ZIDOVUDINEAPOTEX INC
- CzechiaCOMBIVIRViiV Healthcare BV, Amersfoort
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Lamivudine/Zidovudine Viatris
- Cyprus · Lamivudine/Zidovudine Aurobindo
- France · Lamivudine/Zidovudine Arrow, Lamivudine/Zidovudine Viatris
- United Kingdom (Northern Ireland) · Lamivudine/Zidovudine Milpharm, Lamivudine/Zidovudine Mylan
- Iceland · Combivir
- Italy · Lamivudina E Zidovudina Aurobindo, Lamivudina E Zidovudina Mylan
- Liechtenstein · Combivir
- Luxembourg · Lamivudine/Zidovudine Viatris
- Malta · Lamivudine/Zidovudine Mylan
- Netherlands · Lamivudine/Zidovudine Aurobindo, Lamivudine/Zidovudine Viatris
- Norway · Combivir
- Portugal · Lamivudina + Zidovudina Accord, Lamivudina + Zidovudina Aurobindo
- Romania · Lamivudină/Zidovudină Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1fb12b7-a667-483a-b815-0f3edf7f9f1b GET /v1/drugs/f1fb12b7-a667-483a-b815-0f3edf7f9f1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Zidovudine, Lamivudine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about zidovudine, lamivudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.